Evidence map›Paper›PMID 40064612›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2025

Examining Farnesyltransferase Interaction With Cell-Permeable CaaX Peptides and the Role of the CaaX Motif in Biological Activity.

Merlin Klußmann, Jan Reuter, Christian Werner, Ines Neundorf

Abstract read
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Merlin KlußmannInstitute for Biochemistry, Department of Chemistry and Biochemistry, University of Cologne, Cologne, Germany.
Jan ReuterInstitute for Biochemistry, Department of Chemistry and Biochemistry, University of Cologne, Cologne, Germany.
Christian WernerInstitute for Biochemistry, Department of Chemistry and Biochemistry, University of Cologne, Cologne, Germany.
Ines NeundorfInstitute for Biochemistry, Department of Chemistry and Biochemistry, University of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0001-6450-3991

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 411422114NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Recently, we presented cell-permeable CaaX peptides as versatile tools to study intracellular prenylation of proteins. These peptides consist of a cell-penetrating peptide (CPP) and a C-terminal CaaX motif derived from Ras proteins and demonstrated high cellular accumulation and the ability to influence Ras signaling in cancerous cells. Here, we aimed to gain a deeper insight into how such cell-permeable CaaX peptides, particularly the KRas4B-derived CaaX-1 peptide, interact with farnesyltransferase (FTase) and likely influence further intracellular processes. We show that CaaX-1 is farnesylated by FTase ex cellulo and that an intact CaaX motif is required for modification. A competition experiment revealed a slower farnesylation of CaaX-1 by FTase compared to a CaaX motif-containing control peptide. CaaX-1 inhibited farnesylation of this control peptide at considerably lower concentrations; thus, a higher affinity for FTase is hypothesized. Notably, AlphaFold3 not only predicted interactions between CaaX-1 and FTase but also suggested interactions between the peptide and geranylgeranyltransferase type I. This finding encourages further investigation, as cross-prenylation is a well-known drawback of FTase inhibitors. Our results are further evidence for the usefulness of CaaX peptides as tools to study and manipulate the prenylation of proteins. They offer real potential for the development of novel inhibitors targeting the prenylation pathway.

Indexed as

Cell-Penetrating PeptidesFarnesyltranstransferaseAmino Acid MotifsAmino Acid SequenceHumansProtein PrenylationProto-Oncogene Proteins p21(ras)Cell-Penetrating PeptidesFarnesyltranstransferaseProto-Oncogene Proteins p21(ras)CaaX motifcell‐permeable CaaX peptidescompetitionfarnesyltransferaseinhibitionprenylation

Identifiers

PMID40064612
PMCPMC11893521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.